Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Sep 06, 2026
TickeronGET DAILY SIGNALS
Turning Point Brands (TPB): Can It Reclaim the $100 Level After a Sharp Pullback?

Turning Point Brands (TPB): Can It Reclaim the $100 Level After a Sharp Pullback?

Key Takeaways

  • Turning Point Brands recently traded near $75, placing the $100 target roughly 33% above current levels — a meaningful but not unrealistic gap.
  • The $100 mark is a natural psychological milestone, and TPB traded well above it as recently as early 2026, peaking near $147 in February.
  • The strongest bull case rests on rapid growth in nicotine pouches under the FRE and ALP brands, supported by repeated analyst price-target increases.
  • Key risks include a sharp valuation reset, intensifying competition in oral nicotine, and regulatory uncertainty at the FDA.
  • Wall Street's consensus 12-month target sits near $125, implying analysts expect TPB to reclaim $100; the debate is really about the path and the timeline.

The Appeal of the $100 Milestone

Turning Point Brands, Inc. (TPB) is a consumer products company best known for Zig-Zag rolling papers and cigar wraps, Stoker's moist snuff, and a fast-growing portfolio of nicotine pouches. After a powerful rally that carried the stock to a 52-week high of $146.90 in late February 2026, shares have pulled back sharply and recently closed around $75.22.

That retreat has reignited a familiar investor question: can TPB reclaim the psychologically important $100 level? The figure is appealing because it is a round number, because the stock has already traded comfortably above it, and because it sits below the Street's consensus price target — making it a realistic checkpoint rather than a moonshot. I checked this setup using Tickeron’s AI Trend Prediction Engine to gauge the broader momentum.

Where TPB Stands Today

TPB's sharp decline from its February peak reflects a meaningful de-rating. The stock's trailing price-to-earnings (P/E) ratio now sits around 33 times earnings, while its 52-week range spans $65.80 to $146.90. In other words, even after the correction, the shares have not fallen to their low point of the year, but they are closer to that floor than to their former high.

That positioning matters for the $100 question. A return to triple digits would require a gain of roughly 33% from current levels — substantial, but far less dramatic than the move already delivered during the stock's earlier surge.

Catalysts That Could Push TPB Higher

The most important catalyst is the company's pivot toward modern oral nicotine. TPB's FRE brand and the newer ALP line have become the primary growth engine, and management has repeatedly raised full-year guidance as pouch sales accelerate. In late 2025, the company lifted its Modern Oral revenue outlook and delivered quarterly results that exceeded Wall Street's revenue and EBITDA expectations.

That momentum has translated directly into a stream of analyst upgrades. Oppenheimer has maintained an Outperform rating while raising its target from $110 to $120, and Alliance Global Partners lifted its Buy-rated target from $103 to $110. More recently, Needham upgraded the shares with a $125 target. The consensus 12-month price target across covering analysts now sits near $125, with a high estimate around $140 — comfortably above the $100 level in question.

Risks That Could Hold TPB Back

Several obstacles stand between TPB and $100. First, the stock's valuation is not obviously cheap after its run, and the sharp correction suggests some investors view the earlier multiple as unsustainable. Second, the nicotine pouch category is highly competitive, with deep-pocketed rivals aggressively expanding their own oral-nicotine offerings, which could pressure TPB's market share and pricing over time.

Regulatory risk is the third and perhaps most persistent concern. The U.S. Food and Drug Administration (FDA) retains significant authority over nicotine products, and any adverse action on pouch marketing or authorizations could disrupt growth assumptions. Each of these factors could slow the momentum needed to reclaim triple-digit territory.

Key Technical Levels to Watch

From a technical analysis perspective, the 52-week low near $65.80 represents the clearest downside support level, while the round-number $100 mark acts as both a psychological target and a potential resistance level once approached. Between them, the stock's recent trading range has provided no firm intermediate floor, meaning a sustained move toward $100 would likely require buyers to defend progressively higher levels rather than relying on a single catalyst.

What Analysts Are Saying

The analyst community is broadly constructive. With an average rating described as a Strong Buy and a consensus target near $125, the prevailing view already assumes TPB will trade above $100 within the next twelve months. That does not assure the outcome, but it does mean the $100 objective is consistent with — and in fact below — mainstream analyst expectations, rather than a contrarian or aggressive forecast.

My Take on TPB's Path Forward

Can TPB reach $100? The evidence suggests the target is realistic over a twelve-month horizon, primarily because the company's nicotine-pouch growth remains intact and Wall Street's consensus already anticipates a move above that level. The strongest supporting factors are accelerating Modern Oral sales, repeated guidance increases, and a steady series of analyst price-target raises.

The primary risks are equally clear: a still-demanding valuation, fierce competition in oral nicotine, and FDA regulatory uncertainty. Investors monitoring TPB should watch pouch-sales trends, quarterly EBITDA, any changes to analyst targets, and regulatory developments — all of which will determine whether the climb back to triple digits happens sooner, later, or not at all.

Tracking TPB with AI Daily Buy/Sell Signals

I've found Tickeron's AI Daily Buy/Sell Signals helpful for monitoring stocks like TPB. The tool scans the market continuously and generates Buy, Sell, or Hold signals based on technical and AI-driven factors, giving me a clearer sense of shifting trends without constant manual checks.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: TPB

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


TPB in downward trend: 10-day moving average broke below 50-day moving average on November 13, 2026

The 10-day moving average for TPB crossed bearishly below the 50-day moving average on November 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 09, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on TPB as a result. In 48 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 62%.

The Moving Average Convergence Divergence Histogram (MACD) for TPB turned negative on November 10, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 41 similar instances when the indicator turned negative. In 27 of the 41 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.

TPB moved below its 50-day moving average on November 09, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where TPB declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 67%.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 7 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +5.90% 3-day Advance, the price is estimated to grow further. Considering data from situations where TPB advanced for three days, in 231 of 311 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.

TPB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 162 of 222 cases where TPB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 73%.

Fundamental Analysis (Ratings)

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 59 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 60 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 74 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.071) is normal, around the industry mean (-7.297). P/E Ratio (28.154) is within average values for comparable stocks, (12.512). Projected Growth (PEG Ratio) (0.048) is also within normal values, averaging (3.595). Dividend Yield (0.005) settles around the average of (0.060) among similar stocks. P/S Ratio (2.701) is also within normal values, averaging (2.780).

The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. TPB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. TPB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 72, placing this stock worse than average.

Notable companies

The most notable companies in this group are Philip Morris International (NYSE:PM), Altria Group (NYSE:MO).

Industry description

The industry is engaged in the growth, preparation for sale, advertisement, and distribution of tobacco and tobacco-related products like cigarettes. In 2017, tobacco companies spent an estimated $9.36 billion marketing cigarettes and smokeless tobacco in the U.S. – an amount that translates to more than $25 million each day (according to a CDC report). Philip Morris International Inc., Altria Group Inc., and British American Tobacco plc are some major cigar makers. In recent times, vaping or the use of e-cigarette (does not burn tobacco) is gaining momentum – several established cigarette makers are trying to expand their footprint in this new market.

Market Cap

The average market capitalization across the Tobacco Industry is 57.21B. The market cap for tickers in the group ranges from 99 to 308.42B. PM holds the highest valuation in this group at 308.42B. The lowest valued company is AHII at 99.

High and low price notable news

The average weekly price growth across all stocks in the Tobacco Industry was -19%. For the same Industry, the average monthly price growth was -24%, and the average quarterly price growth was -35%. MO experienced the highest price growth at -5%, while XXII experienced the biggest fall at -56%.

Volume

The average weekly volume growth across all stocks in the Tobacco Industry was 90%. For the same stocks of the Industry, the average monthly volume growth was 50% and the average quarterly volume growth was 85%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 40
P/E Growth Rating: 52
Price Growth Rating: 70
SMR Rating: 73
Profit Risk Rating: 71
Seasonality Score: 35 (-100 ... +100)
AI Patterns 1
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of tobacco products

Industry Tobacco

Industry
Tobacco
Address
5201 Interchange Way
Phone
+1 502 778-4421
Employees
484
Web
https://www.turningpointbrands.com
Interact to see
Advertisement
The ADR gapped lower in premarket trading and was at $335.71 in early regular-session trading, -4.65% from Thursday's close of $352.09. The move extends a global AI and chip unwind: investors are cutting crowded semiconductor bets on stretched valuations, rising sector debt, data-center opposition and Nvidia's leadership turmoil, and Nvidia's strong quarter failed to calm sentiment.
Micron shares slid from Thursday's $690.44 close to $635.41, a -7.97% loss, deepening during Friday's regular session after an already soft premarket. The decline was sector-driven, not company-specific: investors kept unwinding AI exposure as Anthropic fell back after its debut, while hawkish Fed comments and doubts about Nvidia's leadership and AI spending returns pressured chip valuations.
Meta Platforms fell from a $596.22 previous close to $583.40, a -2.15% move, with the decline built in premarket trading and held through early Friday action after Thursday's -3.27% drop. The drop was sector-driven, not company-specific: Anthropic slid roughly -6% to -10% premarket on its second trading day, reviving doubts that AI spending will generate returns, and AI-linked megacaps sold off broadly with Nasdaq 100 futures down about -1.5%.
ANT dropped from Thursday's record-debut close of $97.17 to about $88.56 in Friday premarket trading, a -8.86% move ahead of the opening bell, still above its $83 IPO price. The decline came from a broad AI and technology selloff rather than any Anthropic-specific disclosure: Nvidia and AMD traded lower premarket, index futures were sharply down, and renewed doubts over AI spending and valuations drove profit-taking after the +17.07% first-day gain.
IREN dropped -8.33% to $13.21 from Thursday's $14.41 close, with weakness building in premarket and extending through the first hour of regular trading. The decline extends a sector-wide neocloud rout: Anthropic's post-IPO slide and turmoil at Nvidia revived doubts about debt-funded AI data center spending, dragging CoreWeave and Nebius down with it; no IREN-specific news was released.